CLOSE

Specials

  • March
  • June
  • September
  • Bioanalytical Services
  • Life Science Analytics
  • Life Science Compliance
  • Bioanalytical Services APAC
  • APAC
  • Europe

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects...

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial...

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Cyberattacks in Hospitals

Cyberattacks in Hospitals

How AI Can Enhance the Prediction of Immunotherapy

How AI Can Enhance the Prediction of...

How Technology is Reshaping Immunotherapy

How Technology is Reshaping...

A New Field Guide for Earth's Wild Microbes

A New Field Guide for Earth's Wild...

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects...

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial...

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Cyberattacks in Hospitals

Cyberattacks in Hospitals

How AI Can Enhance the Prediction of Immunotherapy

How AI Can Enhance the Prediction of...

How Technology is Reshaping Immunotherapy

How Technology is Reshaping...

A New Field Guide for Earth's Wild Microbes

A New Field Guide for Earth's Wild...

Is Virtual Clinical Trial the Future of Life Sciences Industry?

By Life Sciences Review | Wednesday, May 06, 2020
Tweet

Virtual trials increase the patient pool's size and diversity, accelerate recruiting, and create more informative, clinically relevant data.


FREMONT, CA: Traditional clinical trials that adopt sequential processes are widely accepted and are proven to stick to the industry standards to ensure the efficacy and safety of new medicines, but imagine participating in a clinical trial that does not require trail subjects to travel to a clinical research facility or doctor's office. This is possible through virtual clinical trials through technology devices and social engagement platforms to conduct tests from a patient's home. These processes offer new opportunities for a patient-centric approach to clinical research.


Virtual clinical trials represent a relatively new way of collecting safety and efficacy data from clinical trial participants. These trials take full advantage of technologies and online social engagement platforms to conduct each stage of the clinical trial from the comfort of the patient's home. It includes recruitment, informed consent, patient counseling, through to measuring clinical endpoints and adverse reactions. By depending on electronic processes, virtually conducted clinical trials offer opportunities for a more patient-centered approach.


 


There are several advantages that virtual trials have over the conventional model, which uses multiple study sites and needs numerous patient visits to the site to conduct the study protocol. The most obvious benefit is that the virtual trial design increases patient availability and enrollment in the study. Patient recruitment and enrollment is often the longest stage of a clinical trial, with almost 80 percent of trials failing to meet initial targets. The convenience of a virtual method will increase the number of patients willing and able to enroll. Another advantage to virtual trials is their potential to keep subjects engaged with the study.


Virtual trials also offer the ability to mitigate risk in the drug development process. Data from remote monitoring devices will be accessed by trial investigators in real-time, opening up efficiencies in data cleaning, which could move to an on-going process. Remote monitoring abilities could facilitate an adaptive clinical trial method, enabling improvements in trial design based on the accumulating data. Decisions to stop a drug's development will also be made faster, enhancing patient safety and reducing expenditure on failed trials that have become the norm in the drug discovery process.


See also: Top eClinical Trial Management Consulting/Service Companies


Weekly Brief

loading
Towards a New World Order
> <
  • Other 2021

    Top Vendors

    Current Issue
  • Other 2020

    Top Vendors

    Current Issue

Read Also

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Importance of Biomarkers in Drug Development

Importance of Biomarkers in Drug Development

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects of Immunotherapy

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care
The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech Sector

Why Partner with Bioanalysis Experts?

Why Partner with Bioanalysis Experts?

Cyberattacks in Hospitals

Cyberattacks in Hospitals

Principles of Sustainability in Pharmaceutical Packaging

Principles of Sustainability in Pharmaceutical Packaging
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/is-virtual-clinical-trial-the-future-of-life-sciences-industry-nwid-106.html